GMAB
Genmab A/S · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -13.3% ·
share flow -23.3% ·
net new positions -15.4%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 18.12K | $653,093 | n/a | n/a |
| Q2 2026 | 80 | +9 | 51.55M | $1.41B | +9 | −1 |
| Q1 2026 | 73 | -4 | 45.85M | $1.27B | +5 | −9 |
| Q4 2025 | 77 | 0 | 41.23M | $1.28B | n/a | n/a |
| Q3 2025 | 13 | -2 | 16.25M | $498.26M | n/a | −2 |
| Q2 2025 | 12 | +1 | 18.14M | $374.87M | +1 | n/a |
| Q1 2025 | 9 | 0 | 13.96M | $273.33M | n/a | n/a |
| Q4 2024 | 9 | 0 | 8.94M | $186.52M | +1 | −1 |
| Q3 2024 | 9 | -1 | 7.29M | $175.79M | n/a | −1 |
| Q2 2024 | 10 | n/a | 6.88M | $172.85M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Arrowstreet Capital ✦ | 3.64M | +5.5% | $111.74M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 3.45M | +9.0% | $105.83M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 3 | Renaissance Technologies ✦ | 2.82M | +2.0% | $86.54M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 1.67M | n/a | $51.36M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 5 | Two Sigma Investments ✦ | 1.39M | -14.1% | $42.67M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 1.12M | +64.5% | $34.34M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 7 | Goldman Sachs Group ✦ | 1.12M | n/a | $34.31M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Marshall Wace ✦ | 533.21K | -72.0% | $16.35M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | JPMorgan Chase ✦ | 236.36K | n/a | $7.25M | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 10 | Millennium Management ✦ | 90.91K | -76.5% | $2.79M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 73.70K | +146.0% | $2.26M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 12 | Citadel Advisors ✦ | 51.47K | -98.6% | $1.58M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passive) | 40.88K | +50.7% | $1.25M | 0.0% | ▲ Add | 6 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Point72 Asset Management | $11.13M | was 0.0% |
| Baillie Gifford | $248 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 25.36K shares, $6.69M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.